darTreg infusion

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco

Conditions

Kidney DiseaseLiver Transplantation

Phase 1

Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

TerminatedNCT02188719

National Institute of Allergy and Infectious Diseases (NIAID)Liver Transplantation

Start: 2014-12-17End: 2019-06-18Updated: 2020-09-22

Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )

CompletedNCT02244801

University of California, San FranciscoKidney Disease

Start: 2015-04-30End: 2018-08-28Updated: 2018-10-15

Related Papers

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

2020-05-01321 citations

Does center-specific reporting limit innovation

Liver Transplantation2014-09-13